These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 38184141)

  • 1. Liquid biopsy in lung cancer.
    Li L; Jiang H; Zeng B; Wang X; Bao Y; Chen C; Ma L; Yuan J
    Clin Chim Acta; 2024 Feb; 554():117757. PubMed ID: 38184141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
    Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
    Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy and its role in an advanced clinical trial for lung cancer.
    Johann DJ; Steliga M; Shin IJ; Yoon D; Arnaoutakis K; Hutchins L; Liu M; Liem J; Walker K; Pereira A; Yang M; Jeffus SK; Peterson E; Xu J
    Exp Biol Med (Maywood); 2018 Feb; 243(3):262-271. PubMed ID: 29405770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Educated Platelet RNA and Circulating Free RNA: Emerging Liquid Biopsy Markers for Different Tumor Types.
    Hu H; Song H; Han B; Zhao H; He J
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):80. PubMed ID: 38420812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and treatment monitoring in breast cancer: how liquid biopsy can support patient management.
    Cucchiara F; Scarpitta R; Crucitta S; Scatena C; Arici R; Naccarato AG; Fogli S; Danesi R; Del Re M
    Pharmacogenomics; 2022 Jan; 23(2):119-134. PubMed ID: 35006002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer.
    Zhou H; Zhu L; Song J; Wang G; Li P; Li W; Luo P; Sun X; Wu J; Liu Y; Zhu S; Zhang Y
    Mol Cancer; 2022 Mar; 21(1):86. PubMed ID: 35337361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs.
    Meng Y; Bian L; Zhang M; Bo F; Lu X; Li D
    Biomark Med; 2020 Oct; 14(14):1393-1404. PubMed ID: 33073579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid biopsy in lung cancer management.
    Irofei Zamfir MA; Buburuzan L; Hudiţă A; Gălăţeanu B; Ginghină O; Ion D; Motaş N; Ardeleanu CM; Costache M
    Rom J Morphol Embryol; 2022; 63(1):31-38. PubMed ID: 36074665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in liquid biopsy-based markers in NSCLC.
    Ren XD; Su N; Sun XG; Li WM; Li J; Li BW; Li RX; Lv J; Xu QY; Kong WL; Huang Q
    Adv Clin Chem; 2023; 114():109-150. PubMed ID: 37268331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation.
    Ren F; Fei Q; Qiu K; Zhang Y; Zhang H; Sun L
    J Exp Clin Cancer Res; 2024 Apr; 43(1):96. PubMed ID: 38561776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid biopsy: paving a new avenue for cancer research.
    Kurma K; Eslami-S Z; Alix-Panabières C; Cayrefourcq L
    Cell Adh Migr; 2024 Dec; 18(1):1-26. PubMed ID: 39219215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapy.
    Tomasetti M; Amati M; Neuzil J; Santarelli L
    Lung Cancer; 2017 May; 107():65-72. PubMed ID: 27312601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian Cancer Diagnosis and Prognosis Based on Cell-Free DNA Methylation.
    Gao Y; Zhou N; Liu J
    Cancer Control; 2024; 31():10732748241255548. PubMed ID: 38764160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid biopsy approaches for pleural effusion in lung cancer patients.
    Baburaj G; Damerla RR; Udupa KS; Parida P; Munisamy M; Kolesar J; Rao M
    Mol Biol Rep; 2020 Oct; 47(10):8179-8187. PubMed ID: 33029702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities and Challenges of Liquid Biopsy in Thyroid Cancer.
    Romano C; Martorana F; Pennisi MS; Stella S; Massimino M; Tirrò E; Vitale SR; Di Gregorio S; Puma A; Tomarchio C; Manzella L
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages.
    Guibert N; Pradines A; Favre G; Mazieres J
    Eur Respir Rev; 2020 Mar; 29(155):. PubMed ID: 32051167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of liquid biopsies in gastrointestinal cancer.
    Wu C; Zhang J; Li H; Xu W; Zhang X
    Clin Biochem; 2020 Oct; 84():1-12. PubMed ID: 32540214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid Biopsy in Solid Malignancy.
    Scarlotta M; Simsek C; Kim AK
    Genet Test Mol Biomarkers; 2019 Apr; 23(4):284-296. PubMed ID: 30916594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New perspectives in liquid biopsy for glioma patients.
    Pasqualetti F; Rizzo M; Franceschi S; Lessi F; Paiar F; Buffa FM
    Curr Opin Oncol; 2022 Nov; 34(6):705-712. PubMed ID: 36093876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.